Compounded semaglutide injection is rated high, citing large Phase 3 randomized trials and real-world data, with reductions in fasting glucose, HbA1c, and body weight listed as its measured effects
BPC-157 tends to work more locally when injected near injury sites
FDA Phase 2 trial program for obesity was discontinued without approval
Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial
While yerba mate contains bioactive compoundscaffeine, chlorogenic acid, and polyphenolsresearch shows these may modestly improve insulin sensitivity and energy metabolism, but not GLP-1 secretion specifically